Science Daily Gene Therapy News
-
Gene therapy strategy found effective in mouse model of hereditary disease TSC
Jan 9, 2021 | 21:24 pmPatients with a genetic disorder called tuberous sclerosis complex have noncancerous tumors growing in numerous organs, and their treatment options are limited. A gene therapy strategy effectively treated mice that express one of the mutated genes that cause the disease.
Read more... -
New way to deliver DNA-based therapies for diseases
Dec 18, 2020 | 17:25 pmResearchers have created a new polymer to deliver DNA and RNA-based therapies for diseases. For the first time in the industry, the researchers were able to see exactly how polymers interact with human cells when delivering medicines into the body. This discovery opens the door for more widespread use of polymers in applications like gene therapy and vaccine development.
Read more... -
Scientists develop new gene therapy for eye disease
Nov 26, 2020 | 14:59 pmScientists have developed a new gene therapy approach that offers promise for one day treating an eye disease that leads to a progressive loss of vision and affects thousands of people across the globe. The study also has implications for a much wider suite of neurological disorders associated with aging.
Read more... -
New findings speed progress towards affordable gene therapy
Nov 20, 2020 | 15:59 pmIn a promising advance for affordable, personalized medicine, researchers have used metal-organic frameworks to successfully deliver the genetic snipping tool CRISPR/Cas9 into human cancer cells.
Read more... -
Scientists take major step toward Angelman Syndrome gene therapy
Oct 21, 2020 | 17:23 pmBabies born with a faulty maternal copy of the UBE3A gene will develop Angelman syndrome, a severe neurodevelopmental disorder with no cure and limited treatments. Now, for the first time, scientists show that gene editing and gene therapy techniques can be used to restore UBE3A in human neuron cultures and treat deficits in an animal model of Angelman syndrome.
Read more... -
Restoration of retinal and visual function following gene therapy
Oct 19, 2020 | 21:59 pmA breakthrough study results in the restoration of retinal and visual functions of mice models suffering from inherited retinal disease.
Read more... -
Advanced prostate cancer has an unexpected weakness that can be targeted by drugs
Oct 7, 2020 | 18:30 pmResearchers reported that the SUCLA2 gene is frequently involved in the deletion of the tumor suppressor gene RB1 in advanced prostate cancer. RB1 deletion makes cells resistant to hormone therapy but SUCLA2 deletion induces a metabolic weakness. The study showed that thymoquinone selectively killed SUCLA2-deficient prostate cancer cells in vitro and in vivo. The findings highlight a vulnerability of advanced prostate cancer cells that can be targeted by drugs.
Read more... -
Gene therapy: Novel targets for congenital blindness
Sep 2, 2020 | 15:51 pmRetinitis pigmentosa is the most prevalent form of congenital blindness. Using a retinitis pigmentosa mouse model, researchers have now shown that targeted activation of genes of similar function can compensate for the primary defect.
Read more... -
Progress toward a treatment for Krabbe disease
Aug 26, 2020 | 23:56 pmThe inherited disease, which typically kills children before their second birthday, has no cure, but a new study in a canine model offers hope for an effective gene therapy with lasting results.
Read more... -
Safer CRISPR gene editing with fewer off-target hits
Jul 9, 2020 | 20:16 pmThe CRISPR system is a powerful tool for the targeted editing of genomes, with significant therapeutic potential, but runs the risk of inappropriately editing ''off-target'' sites. However, a new study shows that mutating the enzyme at the heart of the CRISPR gene editing system can improve its fidelity.
Read more... -
Scientists use nanoparticle-delivered gene therapy to inhibit blinding eye disease in rodents
Jul 7, 2020 | 17:32 pmIn experiments in rats and mice, two scientists -- an engineer and an ophthalmologist -- report the successful use of nanoparticles to deliver gene therapy for blinding eye disease. A uniquely engineered large molecule allows researchers to compact large bundles of therapeutic DNA to be delivered into the cells of the eye.
Read more... -
Common inherited genetic variant identified as frequent cause of deafness in adults
Jul 7, 2020 | 02:38 amA common inherited genetic variant is a frequent cause of deafness in adults, meaning that many thousands of people are potentially at risk, reveals new research.
Read more... -
Duchenne muscular dystrophy: Substituting the next-best protein
Apr 24, 2020 | 19:27 pmChildren born with Duchenne muscular dystrophy have a mutation in the X-chromosome gene that would normally code for dystrophin, a protein that provides structural integrity to skeletal muscles. The loss of this protein causes severe symptoms, including deteriorating muscle strength beginning around the age of four. While there is no cure, a promising area of research has developed around the protein utrophin, which is approximately 80 percent identical to dystrophin and even takes its place early during muscle development.
Read more... -
Diabetes reversed in mice with genetically edited stem cells derived from patients
Apr 23, 2020 | 03:40 amResearchers have used induced pluripotent stem cells produced from the skin of a patient with a rare, genetic form of insulin-dependent diabetes, transformed the stem cells into insulin-producing cells, used the CRISPR gene-editing tool to correct a defect that caused the diabetes, and implanted the cells into mice to reverse diabetes in the animals.
Read more... -
Glaucoma could be successfully treated with gene therapy
Apr 21, 2020 | 17:26 pmA new study has shown a common eye condition, glaucoma, could be successfully treated with a single injection using gene therapy, which would improve treatment options, effectiveness and quality of life for many patients.
Read more... -
Novel technology aims to improve treatment of neurological diseases
Apr 18, 2020 | 03:29 amResearchers are developing new 'gene promoters' - which act like switches to turn genes on - for use with gene therapy, the delivery of new genes to replace ones that are faulty. The new promoters work especially well for brain and other neurological disorders and provide longer-lasting functionality compared to other promoters.
Read more... -
Simulations show how to make gene therapy more effective
Apr 17, 2020 | 17:45 pmDiseases with a genetic cause could be treated by supplying a correct version of the faulty gene. However, in practice, delivering new genetic material to human cells is difficult. A promising method for the delivery of such genes involves the use of DNA/lipid complexes (lipoplexes). Scientists have now used advanced simulations to investigate how these lipoplexes deliver DNA fragments into cells. The results can be used to improve their efficiency.
Read more... -
Switching on a key cancer gene could provide first curative treatment for heart disease
Apr 14, 2020 | 14:42 pmResearchers trying to turn off a gene that allows cancers to spread have made a surprising U-turn. By making the gene overactive and functional in the hearts of mice, they have triggered heart cell regeneration. Since adult hearts cannot usually repair themselves once damaged, harnessing the power of this gene represents major progress towards the first curative treatment for heart disease.
Read more... -
New research suggests in-womb gene correction
Apr 6, 2020 | 04:33 amNew research led by hearing scientists suggests an avenue to treat and prevent intractable genetic disorders before birth. Researchers, working with mice, injected a specially designed synthetic molecule into the developing inner ear of fetal mice 12 days after fertilization. The study found that the technique corrected the expression of a mutated gene that causes Usher syndrome.
Read more... -
Gene therapy reverses heart failure in mouse model of Barth syndrome
Mar 9, 2020 | 21:52 pmBarth syndrome is a rare genetic disease in boys that can cause life-threatening heart failure and also weakens the skeletal muscles and the immune system. There is no specific treatment, but new research, involving new mouse models, shows the potential of a gene therapy approach in preventing and reversing cardiac dysfunction in Barth syndrome.
Read more...